Screening Tests Predicting Cancer Metastasis in the Etiology of Pericardial Effusion: HALP Score and PNI

Basit Öğe Kaydı
dc.authoridSahin, Anil/0000-0003-3416-5965
dc.contributor.authorKoyun, Emin
dc.contributor.authorDindas, Ferhat
dc.contributor.authorSahin, Anil
dc.contributor.authorCerik, Idris Bugra
dc.contributor.authorDogdus, Mustafa
dc.date.accessioned2024-10-26T18:09:25Z
dc.date.available2024-10-26T18:09:25Z
dc.date.issued2024
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractBackground: Cancer screening is absolutely necessary in patients with pericardial effusion, given that cancer is one of the most serious diseases in the etiology of pericardial effusion. In previous studies, it was stated that the systemic immune -inflammation index (SII); the prognostic nutrition index (PNI); and the hemoglobin, albumin, lymphocyte, platelet (HALP) score can produce scores related to cancer. Objectives: This study began considering that these scoring systems could predict cancer in the etiology of patients with pericardial effusion. Methods: This study produced a retrospective analysis of patients who underwent pericardiocentesis between 2006 and 2022. Pericardiocentesis was performed in a total of 283 patients with moderate-to-large pericardial effusion or pericardial tamponade within the specified period. HALP, PNI, and SII scores were calculated according to the peripheral venous blood taken before the pericardiocentesis procedure. The statistical significance level was set at p<0.05. Results: The HALP score proved to be 0.173 (0.125-0.175) in cancer patients and 0.32 (0.20-0.49) in non -cancer patients (p<0.001). The PNI score proved to be 33.1 +/- 5.6 in cancer patients and 39.8 +/- 4.8 in non -cancer patients (p<0.001). Conclusion: The HALP score and PNI proved to be easy and fast cancer screening tests that can predict cancer metastasis in the etiology of patients with pericardial effusion.
dc.identifier.doi10.36660/abc.20230376
dc.identifier.issn0066-782X
dc.identifier.issn1678-4170
dc.identifier.issue1
dc.identifier.pmid38451561
dc.identifier.scopus2-s2.0-85187112262
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.36660/abc.20230376
dc.identifier.urihttps://hdl.handle.net/20.500.12418/30089
dc.identifier.volume121
dc.identifier.wosWOS:001182424700001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherArquivos Brasileiros Cardiologia
dc.relation.ispartofArquivos Brasileiros De Cardiologia
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCancer
dc.subjectHemoglobin
dc.subjectAlbumin
dc.subjectLymphocyte
dc.subjectPlatelet (HALP)
dc.subjectPrognostic Nutrition Index
dc.subjectPericardial Effusion
dc.titleScreening Tests Predicting Cancer Metastasis in the Etiology of Pericardial Effusion: HALP Score and PNI
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksyonu
Scopus İndeksli Yayınlar Koleksiyonu